Lonza Group AG (0QNO.L)
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. It supports customers across various aspects of design, development, and manufacturing. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. In addition, this segment provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. The company was incorporated in 1897 and is headquartered in Basel, Switzerland.
Company Info
Highlights
CHF 43.21B
CHF 39.52
0.15
CHF 6.57B
CHF 2.16B
CHF 1.59B
CHF 468.10 - CHF 615.80
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Lonza Group AG (0QNO.L) returned 9.15% year-to-date (YTD) and 11.32% over the past 12 months. Over the past 10 years, 0QNO.L delivered an annualized return of 23.01%, outperforming the S&P 500 benchmark at 10.46%.
0QNO.L
9.15%
10.21%
6.66%
11.32%
5.87%
23.01%
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 0QNO.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 8.68% | -2.54% | -4.11% | 8.11% | -0.60% | 9.15% | |||||||
| 2024 | 23.82% | 6.03% | 16.81% | -4.54% | -6.16% | 1.73% | 18.04% | -4.24% | -3.17% | -0.50% | -2.22% | 2.60% | 52.71% |
| 2023 | 14.72% | 8.48% | -2.93% | 1.20% | 3.11% | -6.36% | -5.60% | -4.22% | -10.78% | -26.55% | 7.16% | 4.06% | -22.02% |
| 2022 | -17.31% | 1.05% | 6.10% | -14.46% | 0.38% | -12.10% | 12.66% | -8.61% | -7.21% | 6.11% | -5.00% | -7.58% | -40.45% |
| 2021 | 0.21% | 3.40% | -10.35% | 10.01% | 0.22% | 13.33% | 5.57% | 11.48% | -9.46% | 6.98% | -0.53% | 2.15% | 34.46% |
| 2020 | 12.90% | -4.40% | 5.18% | 5.11% | 13.33% | 4.74% | 13.63% | -2.53% | 2.64% | -2.36% | 2.59% | -0.14% | 61.06% |
| 2019 | 2.48% | 6.52% | 11.28% | 2.82% | -2.00% | 6.42% | 4.02% | 2.62% | -3.73% | 0.69% | 4.33% | 40.62% | |
| 2018 | -2.31% | -6.20% | -6.74% | 8.47% | 10.23% | -0.86% | 15.34% | 2.23% | 7.34% | -5.46% | 1.83% | -21.18% | -2.73% |
| 2017 | 3.13% | -0.41% | 3.43% | 10.73% | 6.90% | -1.68% | 22.26% | 4.22% | 4.74% | -2.99% | 2.72% | 64.40% | |
| 2016 | -1.77% | -7.37% | 11.57% | 3.05% | -7.03% | 17.00% | 2.13% | -0.31% | 1.08% | -3.28% | -2.95% | 9.93% | |
| 2015 | -1.90% | 1.70% | 9.49% | 8.97% | 3.73% | -3.04% | 5.58% | 6.11% | 8.25% | 2.28% | 48.52% | ||
| 2014 | 3.31% | -0.39% | -0.82% | 6.69% | 5.83% | -4.42% | 18.84% | -5.40% | -2.35% | 4.28% | 26.09% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 0QNO.L is 63, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Lonza Group AG (0QNO.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Lonza Group AG provided a 0.34% dividend yield over the last twelve months, with an annual payout of CHF 2.00 per share. The company has been increasing its dividends for 4 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | CHF 2.00 | CHF 2.00 | CHF 1.75 | CHF 1.50 | CHF 1.50 | CHF 1.38 | CHF 2.75 | CHF 2.75 | CHF 2.55 | CHF 2.32 | CHF 2.32 | CHF 1.99 |
Dividend yield | 0.34% | 0.37% | 0.50% | 0.33% | 0.20% | 0.24% | 0.78% | 1.08% | 0.96% | 1.42% | 1.54% | 1.93% |
Monthly Dividends
The table displays the monthly dividend distributions for Lonza Group AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | |||||||
| 2024 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.00 |
| 2023 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.75 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.75 |
| 2022 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.50 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.50 |
| 2021 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.50 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.50 |
| 2020 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.38 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.38 |
| 2019 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.75 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.75 | |
| 2018 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.75 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.75 |
| 2017 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.55 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.55 | |
| 2016 | CHF 0.00 | CHF 0.00 | CHF 2.32 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.32 | |
| 2015 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.32 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 2.32 | ||
| 2014 | CHF 1.99 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 1.99 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Lonza Group AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Lonza Group AG was 62.45%, occurring on Mar 8, 2024. The portfolio has not yet recovered.
The current Lonza Group AG drawdown is 24.09%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.45% | Aug 31, 2021 | 629 | Mar 8, 2024 | — | — | — |
| -29.11% | May 15, 2017 | 1 | May 15, 2017 | 1 | May 16, 2017 | 2 |
| -27.37% | Oct 2, 2018 | 60 | Dec 27, 2018 | 109 | Jun 12, 2019 | 169 |
| -23.72% | Feb 20, 2020 | 23 | Mar 23, 2020 | 23 | Apr 27, 2020 | 46 |
| -21.68% | Jan 15, 2015 | 2 | Jan 19, 2015 | 6 | Mar 5, 2015 | 8 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Lonza Group AG over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Lonza Group AG, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -100.0%.
Valuation
The Valuation section provides an overview of how Lonza Group AG is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 0QNO.L, comparing it with other companies in the Diagnostics & Research industry. Currently, 0QNO.L has a P/E ratio of 0.1. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 0QNO.L relative to other companies in the Diagnostics & Research industry. Currently, 0QNO.L has a P/S ratio of 6.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 0QNO.L in comparison with other companies in the Diagnostics & Research industry. Currently, 0QNO.L has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |